Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 19, Number 12—December 2013


Guillain-Barré Syndrome Surveillance during National Influenza Vaccination Campaign, New York, USA, 2009

Gregory P. Giambrone1Comments to Author , Shelley M. Zansky, Millicent Eidson, Pamela G. Duncan, Louise-Anne McNutt, and Guthrie S. Birkhead
Author affiliations: New York State Department of Health, Albany, New York, USA (G.P. Giambrone, S.M. Zansky, M. Eidson, P.G. Duncan, G.S. Birkhead); University at Albany School of Public Health, Rensselaer, New York, USA (L.-A. McNutt, G.S. Birkhead)

Main Article

Table 2

Use of primary and secondary diagnosis codes for GBS identified by SPARCS, New York State Department of Health GBS surveillance system, 2009–2010*

Total cases reported
Confirmed/probable cases, no. (%)
Primary 149 116 (78)
Secondary 70 14 (20)
Total 219 130 (59)

*GBS, Guillain-Barré syndrome; SPARCS, Statewide Planning and Research Cooperative System. SPARCS collects administrative data on all hospital discharges in state facilities.

Main Article

1Current affiliation: Weill Cornell Medical College, New York, New York, USA.

Top of Page The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO